Newsroom.
Explore our latest highlights.
Explore our latest highlights.
News
Transfer, Diabetes, IDR,
Helmholtz Munich Spin-Off: New Approach to Type 2 Diabetes Moves Towards Clinical Testing
Viacure Therapeutics, a spin-off from Helmholtz Munich, is preparing a new antibody therapy for type 2 diabetes for clinical testing. The therapy aims to protect insulin-producing beta cells and restore their function. An exclusive licensing…
Research Highlights
Spotlights
Featured Publications
Interviews
Watch Our Image Video
External content
With your consent, third-party content (Source: player.vimeo.com) will be loaded here, which may also use cookies from the respective provider. By using this content, you agree to the use of cookies. Privacy policy
Discover our Public Engagement Activities
External content
With your consent, third-party content (Source: player.vimeo.com) will be loaded here, which may also use cookies from the respective provider. By using this content, you agree to the use of cookies. Privacy policy
Press Contact